Dynavax Technologies
DVAX
#5094
Rank
A$2.60 B
Marketcap
A$22.20
Share price
0.00%
Change (1 day)
3.96%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -A$58.75 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are A$0.33 Billion. In 2024 the company made an earning of A$53.91 Million, an increase over its 2023 earnings that were of A$3.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$58.75 Million-208.95%
2024 A$53.91 M1475.31%
2023 A$3.42 M-99.2%
2022 A$0.43 B238.78%
2021 A$0.12 B-257.89%
2020 -A$80.46 Million-58.58%
2019 -A$0.2 Billion-9.32%
2018 -A$0.22 Billion60.44%
2017 -A$0.14 Billion-15.8%
2016 -A$0.16 Billion4.22%
2015 -A$0.16 Billion16.54%
2014 -A$0.14 Billion37.09%
2013 -A$95.22 Million
2010 -A$68.16 Million214.85%
2009 -A$21.65 Million-37.33%
2008 -A$34.55 Million-66.07%
2007 -A$0.11 Billion16.92%
2006 -A$87.08 Million170.36%
2005 -A$32.21 Million33.39%
2004 -A$24.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$9.89 B-20,481.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.73 B-30,455.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$1.44 B-3,084.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-A$2.8 Billion 5,669.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.01 B-22,792.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.52 B-42,392.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$11.29 B-23,381.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
A$0.21 B-545.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.29 B-4,836.19%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel